YSB (9885.HK) Stock Price

YSB Price

CLOSED
2.88
​
Market closed

Over the last 5 years YSB grew revenue by 28.2% annually, reaching 24.42 B CNY. For YSB, the net margin of 0.7% is up versus -5.0% a few years ago. At today's price the dividend yield works out to roughly 2.81%. The payout ratio is around 27% of earnings.

YSB stock price

Access this data via the Eulerpool API

YSB business model & stock analysis

YSB, Inc. is an investment holding company, which engages in the operation of online platforms. The company is headquartered in Guangzhou, Guangdong and currently employs 6,108 full-time employees. The company went IPO on 2023-06-28. The firm is mainly engaged in the wholesale and retail of pharmaceuticals and healthcare products on offline or online platforms. The firm provides an online platform for pharmaceutical distributors to sell their pharmaceuticals and healthcare products. The firm also provides software-as-a-service (SaaS) solutions for pharmacies, provides medical testing services for primary medical institutions, sells smart unmanned pharmaceutical booth to third-party pharmacies, as well as provides maintenance and technical support services in relation to the smart unmanned pharmaceutical booth to third-party pharmacies. The firm principally conducts its businesses in the domestic market.

Frequently asked questions about YSB

7 analysts currently rate the YSB stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect YSB to generate revenue of 23.68 B CNY and earnings per share of 0.36 CNY.

Converted at the current exchange rate, the YSB share trades at 0.38 EUR (2.88 CNY).

The expected revenue of YSB is 23.68 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of YSB is 248.69 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of YSB is currently 8.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the YSB stock.

The price-to-sales ratio (P/S) of YSB is currently 0.08. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the YSB stock.

The Eulerpool Quality Score for YSB is 5/10.

The ISIN of YSB is KYG9879S1003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of YSB is 9885.HK. The ticker symbol is used to trade YSB shares on the stock exchange.

Fair ValueTerminal
2.65 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
4.00 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ysbang.cn
Country
Currency
CNY
Initial public offering
Jun 28, 2023
ISIN
KYG9879S1003
Cusip
G9879S100
Market capitalization
1.89 B CNYSmall Cap
52-Week Range
PEG
0.53
P/E ratio
P/Ee 2026
7.62
P/Ee 2027
5.83
P/Ee 2028
4.28
P/S
P/Se
0.08
EV/EBIT
—
P/B Ratio
0.67
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.52 %
Dividend
Dividend yield
2.81 %
Est. Dividend Yield
2.81 %
Payout Ratio
27.10 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
1 year
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
10.00 %
Last updated Oct 13, 2026, 1:13 AM

YSB Peer Group

YSB FIGI

9885:HK · BBG01H0G6FG89885:H1 · BBG01J687DG09885:H2 · BBG01J68SHN0

All fundamentals and in-depth analysis of YSB

Our stock analysis for YSB stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of YSB. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.